Uwe Nicolay

1.6k total citations
34 papers, 1.2k citations indexed

About

Uwe Nicolay is a scholar working on Epidemiology, Hematology and Immunology. According to data from OpenAlex, Uwe Nicolay has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Hematology and 9 papers in Immunology. Recurrent topics in Uwe Nicolay's work include Influenza Virus Research Studies (12 papers), Respiratory viral infections research (8 papers) and Immune Response and Inflammation (8 papers). Uwe Nicolay is often cited by papers focused on Influenza Virus Research Studies (12 papers), Respiratory viral infections research (8 papers) and Immune Response and Inflammation (8 papers). Uwe Nicolay collaborates with scholars based in Germany, United States and Italy. Uwe Nicolay's co-authors include Giovanni Della Cioppa, Giuseppe Del Giudice, Steven Black, Rino Rappuoli, Kelly Lindert, Theodore F. Tsai, Ralf Clemens, Timo Vesikari, Nicola Groth and Michele Pellegrini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and The Journal of Infectious Diseases.

In The Last Decade

Uwe Nicolay

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe Nicolay Germany 17 780 338 305 143 128 34 1.2k
Greet J. Boland Netherlands 20 862 1.1× 380 1.1× 236 0.8× 114 0.8× 63 0.5× 64 1.5k
Jaythoon Hassan Ireland 22 412 0.5× 530 1.6× 204 0.7× 124 0.9× 81 0.6× 63 1.3k
Karlis Pauksens Sweden 23 964 1.2× 240 0.7× 385 1.3× 113 0.8× 87 0.7× 47 1.6k
Wivine Burny Belgium 16 293 0.4× 438 1.3× 269 0.9× 179 1.3× 89 0.7× 27 841
Susette Audet United States 24 1.4k 1.8× 652 1.9× 624 2.0× 147 1.0× 36 0.3× 38 2.0k
Victor H. Ferreira Canada 20 437 0.6× 367 1.1× 546 1.8× 127 0.9× 24 0.2× 59 1.3k
Daniela Huzly Germany 22 582 0.7× 162 0.5× 570 1.9× 151 1.1× 42 0.3× 65 1.4k
Pentti Ukkonen Finland 18 599 0.8× 152 0.4× 300 1.0× 238 1.7× 46 0.4× 36 1.1k
Pilar Pérez‐Romero Spain 22 782 1.0× 197 0.6× 382 1.3× 126 0.9× 51 0.4× 73 1.2k
Mary Rinki United States 10 654 0.8× 292 0.9× 181 0.6× 32 0.2× 42 0.3× 10 893

Countries citing papers authored by Uwe Nicolay

Since Specialization
Citations

This map shows the geographic impact of Uwe Nicolay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Nicolay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Nicolay more than expected).

Fields of papers citing papers by Uwe Nicolay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Nicolay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Nicolay. The network helps show where Uwe Nicolay may publish in the future.

Co-authorship network of co-authors of Uwe Nicolay

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Nicolay. A scholar is included among the top collaborators of Uwe Nicolay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Nicolay. Uwe Nicolay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicolay, Uwe, et al.. (2023). The Impact of Educational Intervention on Willingness to Enroll in a Clinical Trial of a Gonorrhea Vaccine. Vaccines. 11(3). 648–648. 1 indexed citations
2.
Nicolay, Uwe, Esther Heijnen, Pantaleo Nacci, P. Patriarca, & Brett Leav. (2019). Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience. International Journal of Infectious Diseases. 85. S1–S9. 35 indexed citations
3.
Black, Steven, Uwe Nicolay, Giuseppe Del Giudice, & Rino Rappuoli. (2015). Influence of Statins on Influenza Vaccine Response in Elderly Individuals. The Journal of Infectious Diseases. 213(8). 1224–1228. 56 indexed citations
4.
Frey, Sharon E., Humberto Reynales, Nancy Bermal, et al.. (2014). Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 32(39). 5027–5034. 110 indexed citations
5.
Cioppa, Giovanni Della, Uwe Nicolay, Kelly Lindert, et al.. (2014). A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration. Human Vaccines & Immunotherapeutics. 10(6). 1701–1710. 26 indexed citations
6.
Cioppa, Giovanni Della, Uwe Nicolay, Kelly Lindert, et al.. (2012). Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59®adjuvant. Human Vaccines & Immunotherapeutics. 8(2). 216–227. 30 indexed citations
7.
Tsai, Theodore F., Pantaleo Nacci, Uwe Nicolay, et al.. (2011). Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. Scandinavian Journal of Infectious Diseases. 43(9). 702–706. 72 indexed citations
8.
Cioppa, Giovanni Della, Timo Vesikari, Étienne Sokal, Kelly Lindert, & Uwe Nicolay. (2011). Trivalent and quadrivalent MF59®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study. Vaccine. 29(47). 8696–8704. 34 indexed citations
9.
Black, Steven, Uwe Nicolay, Timo Vesikari, et al.. (2011). Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children. The Pediatric Infectious Disease Journal. 30(12). 1081–1085. 272 indexed citations
10.
Black, Steven, Giovanni Della Cioppa, Anne Malfroot, et al.. (2010). Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis. Vaccine. 28(45). 7331–7336. 35 indexed citations
11.
Pellegrini, Michele, Uwe Nicolay, Kelly Lindert, Nicola Groth, & Giovanni Della Cioppa. (2009). MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database. Vaccine. 27(49). 6959–6965. 139 indexed citations
12.
Kang, Minhee & Uwe Nicolay. (2008). Evaluation of operational chronic infection endpoints for HCV vaccine trials. Contemporary Clinical Trials. 29(5). 671–678. 2 indexed citations
13.
Ternák, Gábor, et al.. (2007). Tick-Borne Encephalitis (TBE) Vaccination in Children: Advantage of the Rapid Immunization Schedule (i.e., days 0, 7, 21). Human Vaccines. 3(2). 42–47. 20 indexed citations
14.
Schönfeld, Christian, et al.. (2006). Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule. International Journal of Medical Microbiology. 296. 208–212. 14 indexed citations
15.
Dickneite, Gerhard, et al.. (2002). The Importance of Factor XIII as a Component of Fibrin Sealants. Journal of Surgical Research. 107(2). 186–195. 31 indexed citations
16.
Nicolay, Uwe, et al.. (1999). Diphtheria booster vaccination: one or two injections?. Vaccine. 17(18). 2223–2228. 16 indexed citations
17.
Czech, Jörg, et al.. (1996). Influence of Recombinant Hirudin on Tissue-Factor-Induced Activation of Coagulation in Rabbits. Pathophysiology of Haemostasis and Thrombosis. 26(4). 179–186. 1 indexed citations
18.
Link, Hartmut, Thomas Brune, G Hübner, et al.. (1993). Effect of recombinant human erythropoietin after allogeneic bone marrow transplantation. Annals of Hematology. 67(4). 169–173. 11 indexed citations
19.
Schulz, G., et al.. (1991). New Therapeutic Modalities for the Clinical Use of rhGM-CSF in Patients with Malignancies. American Journal of Clinical Oncology. 14. S19–26. 11 indexed citations
20.
Herrmann, F., G. Schulz, Karin Kolbe, et al.. (1990). Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Neutropenia and Related Morbidity Induced by Myelotoxic Chemotherapy. Hämatologie und Bluttransfusion. 33. 717–723. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Greet J. Boland Breakdown of academic impact, for papers by Jaythoon Hassan Breakdown of academic impact, for papers by Karlis Pauksens Breakdown of academic impact, for papers by Wivine Burny Breakdown of academic impact, for papers by Susette Audet Breakdown of academic impact, for papers by Victor H. Ferreira Breakdown of academic impact, for papers by Daniela Huzly Breakdown of academic impact, for papers by Pentti Ukkonen Breakdown of academic impact, for papers by Pilar Pérez‐Romero Breakdown of academic impact, for papers by Mary Rinki
Rankless by CCL
2026